This is concurrent with previous reports of quercetin-mediated inhibition NF-κB signaling in several disease models like cancer and inflammation (Granado-Serrano et al., 2010; Chirumbolo, 2013; Indra et al., 2013; Zhang et al., 2015; Cheng et al., 2019). The gene discussed is NFKB1; the disease is cancer.